General Information of the Compound
| Compound ID |
CP0514006
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(4-(3-(1,2-dimethyl-7-(3-nitrophenyl)-1H-pyrrolo[3,2-d]pyridazin-4-ylamino)propyl)piperazin-1-yl)(pyrazin-2-yl)methanone
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C26H29N9O3
|
||||||||||||||||||
| Molecular Weight |
515.578
|
||||||||||||||||||
| Canonical SMILES |
Cc1cc2c(NCCCN3CCN(CC3)C(=O)c3cnccn3)nnc(-c3cccc(c3)[N+]([O-])=O)c2n1C
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C26H29N9O3/c1-18-15-21-24(32(18)2)23(19-5-3-6-20(16-19)35(37)38)30-31-25(21)29-7-4-10-33-11-13-34(14-12-33)26(36)22-17-27-8-9-28-22/h3,5-6,8-9,15-17H,4,7,10-14H2,1-2H3,(H,29,31)
Show/Hide
|
||||||||||||||||||
| InChIKey |
UMUUWNFRPISCHD-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01305, 3',5'-cyclic-AMP phosphodiesterase 4B
Protein ID: PT01538, 3',5'-cyclic-AMP phosphodiesterase 4D